Trial intelligence / Profile preview

Rivastigmine Transdermal Patch in Mild to Moderate Alzheimer's Disease

jRCT2080220356Phase 3

Sponsor

Novartis

Start

Mar 2007

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1